Table 4.
Clinical characteristics of the subjects stratified according to the genotypes of I/D polymorphism of ADRA2B gene.
| Groups | BMI | SBP | DBP | BGL | HDL-C | LDL-C | TG | TC |
|---|---|---|---|---|---|---|---|---|
| Group 1 | ||||||||
| II | 26.28±5.52 | 163.67±21.79 | 97.17±5.00 | 5.07±0.66 | 0.89±0.37 | .3.37±0.71 | 2.12±0.93 | 4.68±0.59 |
| ID | 25.91±4.02 | 159.03±16.47 | 96.18±7.95 | 5.31±0.59 | 0.98±0.47 | 3.32±0.91 | 2.17±1.39 | 4.80±1.00 |
| DD | 25.18±4.11 | 160.87±22.08 | 99.70±13.88 | 5.19±0.47 | 0.78±0.33 | 3.72±1.79 | 1.88±1.01 | 5.01±1.79 |
| p value | 0.724 | 0.841 | 0.428 | 0.487 | 0.163 | 0.486 | 0.624 | 0.789 |
| Group 2 | ||||||||
| II | 25.47±4.40 | 164.86±21.54 | 96.29±2.50 | 13.14±4.40 | 0.65±0.25 | 4.02±0.89 | 1.95±0.64 | 5.06±0.80 |
| ID | 27.01±3.39 | 160.26±17.82 | 93.55±5.21 | 11.04±3.92 | 0.78±0.35 | 3.79±1.32 | 2.09±1.11 | 5.11±1.44 |
| DD | 26.58±3.76 | 158.65±21.02 | 93.45±3.15 | 12.59±6.44 | 0.83±0.22 | 3.96±2.09 | 1.87±0.97 | 5.29±2.15 |
| p value | 0.575 | 0.764 | 0.305 | 0.382 | 0.428 | 0.886 | 0.747 | 0.911 |
| Group 3 | ||||||||
| II | 22.71±2.82 | 125.11±9.26 | 76.17±6.81 | 4.52±0.84 | 1.12±0.51 | 3.38±1.15 | 1.37±0.70 | 5.17±1.34 |
| ID | 24.21±4.54 | 126.68±8.25 | 78.46±7.30 | 4.68±0.93 | 1.10±0.39 | 3.42±1.37 | 1.78±1.13 | 5.05±1.37 |
| DD | 24.57±4.35 | 125.59±9.62 | 78.18±7.10 | 4.54±0.96 | 1.13±0.33 | 3.31±1.00 | 1.78±1.30 | 5.19±1.51 |
| p value | 0.329 | 0.807 | 0.524 | 0.780 | 0.969 | 0.949 | 0.383 | 0.923 |
Data are presented as mean±SD, p value>0.05.